AptarGroup (ATR) Receives FDA 510(k) Clearance for HeroTracker Sense

AptarGroup, Inc. (NYSE:ATR) is one of the Best 52-Week Low Mid Cap Stocks to Buy Now. On October 16, AptarGroup, Inc. (NYSE:ATR) announced receiving FDA 510(k) clearance for HeroTracker Sense as a Class II medical device.

HeroTracker Sense is a Bluetooth-enabled small sensor that can be attached to inhalers. The device connects the inhaler with a smartphone application that sends reminders, offers educational tips, and provides real-time feedback.

Following the FDA approval, on October 17, Matt Roberts from Raymond James reiterated a Buy rating on AptarGroup, Inc. (NYSE:ATR) with a price target of $172.

AptarGroup, Inc. (NYSE:ATR) designs and manufactures dosing, dispensing, and protection technologies for various products.

While we acknowledge the potential of ATR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.